University of Manchester Innovation Center

Dementia Consortium funds dementia treatments team

Wednesday, March 15, 2017

The Dementia Consortium, a public-private partnership initiative bridging the gap between academic research and the pharmaceutical industry, is supporting a project led by Dr. David Brough at the University of Manchester to develop novel therapeutics for Alzheimer’s disease targeting the immune system. This is the fifth project supported by the Dementia Consortium, and has been awarded £191,757 by the initiative.

[Read More]

Orchard Therapeutics launches, partners on transformative gene therapies

Monday, May 9, 2016

Orchard Therapeutics, a clinical-stage biotechnology company with operations in London and the U.S., has officially launched with a £21-million Series A financing led by F-Prime Capital. As part of its launch, the company has announced formal partnerships with University College London (UCL), Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), the University of Manchester, the University of California Los Angeles (UCLA) and Boston Children’s Hospital for the development of transformative gene therapies for serious and life-threatening orphan diseases.

[Read More]

Certara endows lectureship in precision dosing at University of Manchester

Thursday, June 4, 2015

Certara, a global biosimulation technology-enabled drug development consultancy, is endowing a new three-year, full-time position—the Certara lecturer in precision dosing—at the Manchester Pharmacy School, the University of Manchester, England. This lectureship is intended to advance teaching and research into individual dose optimization modeling, and to demonstrate its application to cancer, pediatric and biologic therapies.

[Read More]

AstraZeneca, Manchester University form Advanced Drug Delivery Center

Thursday, November 6, 2014

The University of Manchester and AstraZeneca have entered into a strategic collaboration to develop cutting-edge technologies designed to enhance the way drugs work and deliver better health outcomes for patients. Together, they are launching the North West Center for Advanced Drug Delivery, which will be housed in Manchester Pharmacy School and will have links into a wide range of research groups throughout the university.

[Read More]

MAHSC, Roche partner

Wednesday, March 12, 2014

Researchers and clinicians from Manchester Academic Health Science Center (MAHSC), a partnership involving the University of Manchester and six NHS Trusts, have launched a major partnership with global pharmaceutical company Roche. The new relationship will boost clinical research studies, which could lead to the development of new drugs and diagnostic tools and give patients in the region greater access to new treatments in development.

[Read More]